NU 641 – ADVANCED CLINICAL PHARMACOLOGY EXAM 2 QUESTIONS AND DETAILED
SOLUTIONS JUST RELEASED.PDF
Core Domains
Pharmacokinetics and Pharmacodynamics
Infectious Disease Pharmacology and Antimicrobial Stewardship
Cardiovascular Pharmacology
Endocrine Pharmacology
Central Nervous System Pharmacology
Autonomic Nervous System Pharmacology
Chemotherapeutic and Immunologic Agents
Gastrointestinal and Anti-Inflammatory Pharmacology
Introduction
The NU 641 Advanced Clinical Pharmacology Exam 2 evaluates the graduate nursing student's
mastery of pharmacotherapeutic principles essential for advanced practice. The assessment
measures understanding of drug mechanisms, pharmacokinetic parameters, adverse drug
reactions, drug interactions, and evidence-based prescribing across major therapeutic categories.
Content emphasizes clinical decision-making, patient safety, and the application of
pharmacologic principles to diverse patient populations. This comprehensive test bank challenges
the candidate to analyze clinical scenarios, select appropriate pharmacologic agents, monitor for
adverse effects, and apply pharmacogenomic considerations, preparing the advanced practice
nurse for safe and effective prescriptive authority.
SECTION ONE: QUESTIONS 1–100
1. A 68-year-old patient with chronic kidney disease is prescribed a medication with a half-
life of 8 hours. Which pharmacokinetic parameter is most important to assess when
determining the appropriate dose?
A. Bioavailability
B. Volume of distribution
C. Creatinine clearance
D. Protein binding
,🟢 C. Creatinine clearance
🔴 RATIONALE: Creatinine clearance estimates glomerular filtration rate and is the most
important parameter for adjusting renally eliminated drugs. In chronic kidney disease, reduced
creatinine clearance leads to drug accumulation and toxicity risk.
2. A nurse practitioner is reviewing the difference between pharmacokinetics and
pharmacodynamics. Which statement best describes pharmacodynamics?
A. The study of how the body affects the drug
B. The study of how the drug affects the body
C. The study of drug absorption and distribution
D. The study of drug metabolism and excretion
🟢 B. The study of how the drug affects the body
🔴 RATIONALE: Pharmacodynamics describes the biochemical and physiological effects of
drugs on the body, including receptor binding, signal transduction, and dose-response
relationships. Pharmacokinetics describes how the body affects the drug (absorption,
distribution, metabolism, excretion).
3. A patient with a history of cirrhosis is prescribed a medication that undergoes extensive
first-pass metabolism. Which action should the nurse practitioner take?
A. Increase the dose to compensate for impaired metabolism
B. Consider a reduced dose or alternative route of administration
C. Administer the medication with food to enhance absorption
D. Monitor for decreased therapeutic effect
🟢 B. Consider a reduced dose or alternative route of administration
🔴 RATIONALE: Cirrhosis impairs hepatic function and first-pass metabolism, leading to
increased bioavailability and drug accumulation. A reduced dose or alternative route (e.g.,
transdermal, IV) may be necessary to prevent toxicity.
4. Which of the following antibiotics is concentration-dependent and requires monitoring of
peak levels for efficacy?
,A. Penicillin G
B. Gentamicin
C. Erythromycin
D. Clindamycin
🟢 B. Gentamicin
🔴 RATIONALE: Aminoglycosides such as gentamicin exhibit concentration-dependent killing,
meaning higher peak concentrations correlate with greater bactericidal activity. Peak and
trough levels must be monitored to optimize efficacy and minimize nephrotoxicity and
ototoxicity.
5. A 72-year-old patient with atrial fibrillation is started on warfarin. Which parameter
should the nurse practitioner monitor to assess therapeutic effect?
A. aPTT
B. INR
C. Platelet count
D. Bleeding time
🟢 B. INR
🔴 RATIONALE: The International Normalized Ratio (INR) is the standard monitoring parameter
for warfarin therapy. For atrial fibrillation, the target INR is typically 2.0–3.0.
6. A patient taking warfarin is prescribed trimethoprim-sulfamethoxazole for a urinary tract
infection. Which interaction is most concerning?
A. Decreased warfarin absorption
B. Increased warfarin metabolism
C. Increased risk of bleeding
D. Decreased anticoagulant effect
🟢 C. Increased risk of bleeding
🔴 RATIONALE: Trimethoprim-sulfamethoxazole inhibits cytochrome P450 enzymes and
displaces warfarin from protein binding, increasing the anticoagulant effect and bleeding risk.
Close INR monitoring is required.
, 7. A 45-year-old woman with type 2 diabetes is prescribed metformin. Which laboratory test
should be obtained before initiating therapy?
A. Serum creatinine
B. Liver function tests
C. Serum potassium
D. Thyroid-stimulating hormone
🟢 A. Serum creatinine
🔴 RATIONALE: Metformin is contraindicated in renal impairment due to the risk of lactic
acidosis. Serum creatinine should be obtained at baseline and monitored periodically to assess
renal function.
8. A patient with asthma is prescribed albuterol. Which receptor does albuterol primarily
stimulate?
A. Beta-1 adrenergic receptors
B. Beta-2 adrenergic receptors
C. Alpha-1 adrenergic receptors
D. Muscarinic receptors
🟢 B. Beta-2 adrenergic receptors
🔴 RATIONALE: Albuterol is a short-acting beta-2 agonist that causes bronchodilation by
relaxing bronchial smooth muscle. Beta-2 selectivity minimizes cardiac side effects compared
to non-selective beta agonists.
9. A patient with depression is started on sertraline. Which adverse effect should the nurse
practitioner monitor for during the first few weeks of therapy?
A. Hypertension
B. Increased suicidal ideation
C. Bradycardia
D. Weight gain
🟢 B. Increased suicidal ideation
SOLUTIONS JUST RELEASED.PDF
Core Domains
Pharmacokinetics and Pharmacodynamics
Infectious Disease Pharmacology and Antimicrobial Stewardship
Cardiovascular Pharmacology
Endocrine Pharmacology
Central Nervous System Pharmacology
Autonomic Nervous System Pharmacology
Chemotherapeutic and Immunologic Agents
Gastrointestinal and Anti-Inflammatory Pharmacology
Introduction
The NU 641 Advanced Clinical Pharmacology Exam 2 evaluates the graduate nursing student's
mastery of pharmacotherapeutic principles essential for advanced practice. The assessment
measures understanding of drug mechanisms, pharmacokinetic parameters, adverse drug
reactions, drug interactions, and evidence-based prescribing across major therapeutic categories.
Content emphasizes clinical decision-making, patient safety, and the application of
pharmacologic principles to diverse patient populations. This comprehensive test bank challenges
the candidate to analyze clinical scenarios, select appropriate pharmacologic agents, monitor for
adverse effects, and apply pharmacogenomic considerations, preparing the advanced practice
nurse for safe and effective prescriptive authority.
SECTION ONE: QUESTIONS 1–100
1. A 68-year-old patient with chronic kidney disease is prescribed a medication with a half-
life of 8 hours. Which pharmacokinetic parameter is most important to assess when
determining the appropriate dose?
A. Bioavailability
B. Volume of distribution
C. Creatinine clearance
D. Protein binding
,🟢 C. Creatinine clearance
🔴 RATIONALE: Creatinine clearance estimates glomerular filtration rate and is the most
important parameter for adjusting renally eliminated drugs. In chronic kidney disease, reduced
creatinine clearance leads to drug accumulation and toxicity risk.
2. A nurse practitioner is reviewing the difference between pharmacokinetics and
pharmacodynamics. Which statement best describes pharmacodynamics?
A. The study of how the body affects the drug
B. The study of how the drug affects the body
C. The study of drug absorption and distribution
D. The study of drug metabolism and excretion
🟢 B. The study of how the drug affects the body
🔴 RATIONALE: Pharmacodynamics describes the biochemical and physiological effects of
drugs on the body, including receptor binding, signal transduction, and dose-response
relationships. Pharmacokinetics describes how the body affects the drug (absorption,
distribution, metabolism, excretion).
3. A patient with a history of cirrhosis is prescribed a medication that undergoes extensive
first-pass metabolism. Which action should the nurse practitioner take?
A. Increase the dose to compensate for impaired metabolism
B. Consider a reduced dose or alternative route of administration
C. Administer the medication with food to enhance absorption
D. Monitor for decreased therapeutic effect
🟢 B. Consider a reduced dose or alternative route of administration
🔴 RATIONALE: Cirrhosis impairs hepatic function and first-pass metabolism, leading to
increased bioavailability and drug accumulation. A reduced dose or alternative route (e.g.,
transdermal, IV) may be necessary to prevent toxicity.
4. Which of the following antibiotics is concentration-dependent and requires monitoring of
peak levels for efficacy?
,A. Penicillin G
B. Gentamicin
C. Erythromycin
D. Clindamycin
🟢 B. Gentamicin
🔴 RATIONALE: Aminoglycosides such as gentamicin exhibit concentration-dependent killing,
meaning higher peak concentrations correlate with greater bactericidal activity. Peak and
trough levels must be monitored to optimize efficacy and minimize nephrotoxicity and
ototoxicity.
5. A 72-year-old patient with atrial fibrillation is started on warfarin. Which parameter
should the nurse practitioner monitor to assess therapeutic effect?
A. aPTT
B. INR
C. Platelet count
D. Bleeding time
🟢 B. INR
🔴 RATIONALE: The International Normalized Ratio (INR) is the standard monitoring parameter
for warfarin therapy. For atrial fibrillation, the target INR is typically 2.0–3.0.
6. A patient taking warfarin is prescribed trimethoprim-sulfamethoxazole for a urinary tract
infection. Which interaction is most concerning?
A. Decreased warfarin absorption
B. Increased warfarin metabolism
C. Increased risk of bleeding
D. Decreased anticoagulant effect
🟢 C. Increased risk of bleeding
🔴 RATIONALE: Trimethoprim-sulfamethoxazole inhibits cytochrome P450 enzymes and
displaces warfarin from protein binding, increasing the anticoagulant effect and bleeding risk.
Close INR monitoring is required.
, 7. A 45-year-old woman with type 2 diabetes is prescribed metformin. Which laboratory test
should be obtained before initiating therapy?
A. Serum creatinine
B. Liver function tests
C. Serum potassium
D. Thyroid-stimulating hormone
🟢 A. Serum creatinine
🔴 RATIONALE: Metformin is contraindicated in renal impairment due to the risk of lactic
acidosis. Serum creatinine should be obtained at baseline and monitored periodically to assess
renal function.
8. A patient with asthma is prescribed albuterol. Which receptor does albuterol primarily
stimulate?
A. Beta-1 adrenergic receptors
B. Beta-2 adrenergic receptors
C. Alpha-1 adrenergic receptors
D. Muscarinic receptors
🟢 B. Beta-2 adrenergic receptors
🔴 RATIONALE: Albuterol is a short-acting beta-2 agonist that causes bronchodilation by
relaxing bronchial smooth muscle. Beta-2 selectivity minimizes cardiac side effects compared
to non-selective beta agonists.
9. A patient with depression is started on sertraline. Which adverse effect should the nurse
practitioner monitor for during the first few weeks of therapy?
A. Hypertension
B. Increased suicidal ideation
C. Bradycardia
D. Weight gain
🟢 B. Increased suicidal ideation
